Blood-borne biomarkers of MS relapse identified

NEW ORLEANS – Three potentially useful blood-based biomarkers of relapse and of the response to glatiramer acetate treatment have been identified in patients with relapsing-remitting multiple...

Source: Clinical Neurology News - February 24, 2016 Category: Neurology Source Type: news